Gyeonggi-do, South Korea

Hyelim Choi

This inventor holds 1 USPTO granted patent. Top assignee: Kookmin University Industry Academy Cooperation Foundation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyelim Choi. Retrieved from https://idiyas.com/inventor/hyelim-choi-3f7h662d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyelim Choi and Her Patent on SARS-CoV-2 Antibodies.

Introduction

Hyelim Choi is an inventor associated with Gyeonggi-do, South Korea. Her patent work includes research on antibodies that bind to the SARS-CoV-2 spike protein.

Latest Patents

Choi is listed on 1 patent: “Antibody Binding Specifically to SARS-CoV-2 S Protein or Antigen-Binding Fragment Thereof, Bispecific Antibody, and Uses Thereof.” The invention concerns antibodies and antibody fragments that specifically bind to the SARS-CoV-2 spike protein, including bispecific antibodies and their potential uses.

Career Highlights

Choi is associated with the Kookmin University Industry Academy Cooperation Foundation, which connects university research with industry collaboration. Her listed patent reflects work in antibody research related to SARS-CoV-2.

Collaborations

Sukmook Lee and Ji Woong Kim are listed as Choi’s coworkers and collaborators associated with the patent.

Conclusion

Hyelim Choi’s patent work highlights her contribution to antibody research targeting the SARS-CoV-2 spike protein through an invention associated with the Kookmin University Industry Academy Cooperation Foundation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…